248 related articles for article (PubMed ID: 9398841)
1. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion.
White JK; Auerbach W; Duyao MP; Vonsattel JP; Gusella JF; Joyner AL; MacDonald ME
Nat Genet; 1997 Dec; 17(4):404-10. PubMed ID: 9398841
[TBL] [Abstract][Full Text] [Related]
2. Genetics and neuropathology of Huntington's disease.
Reiner A; Dragatsis I; Dietrich P
Int Rev Neurobiol; 2011; 98():325-72. PubMed ID: 21907094
[TBL] [Abstract][Full Text] [Related]
3. Splice modulators target PMS1 to reduce somatic expansion of the Huntington's disease-associated CAG repeat.
McLean ZL; Gao D; Correia K; Roy JCL; Shibata S; Farnum IN; Valdepenas-Mellor Z; Kovalenko M; Rapuru M; Morini E; Ruliera J; Gillis T; Lucente D; Kleinstiver BP; Lee JM; MacDonald ME; Wheeler VC; Mouro Pinto R; Gusella JF
Nat Commun; 2024 Apr; 15(1):3182. PubMed ID: 38609352
[TBL] [Abstract][Full Text] [Related]
4. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.
Borrell-Pagès M; Zala D; Humbert S; Saudou F
Cell Mol Life Sci; 2006 Nov; 63(22):2642-60. PubMed ID: 17041811
[TBL] [Abstract][Full Text] [Related]
5. Mouse Huntington's disease homolog mRNA levels: variation and allele effects.
Dixon KT; Cearley JA; Hunter JM; Detloff PJ
Gene Expr; 2004; 11(5-6):221-31. PubMed ID: 15200234
[TBL] [Abstract][Full Text] [Related]
6. Mouse models of Huntington's disease and methodological considerations for therapeutic trials.
Ferrante RJ
Biochim Biophys Acta; 2009 Jun; 1792(6):506-20. PubMed ID: 19362590
[TBL] [Abstract][Full Text] [Related]
7. Hypomorphic mutation of the mouse Huntington's disease gene orthologue.
Murthy V; Tebaldi T; Yoshida T; Erdin S; Calzonetti T; Vijayvargia R; Tripathi T; Kerschbamer E; Seong IS; Quattrone A; Talkowski ME; Gusella JF; Georgopoulos K; MacDonald ME; Biagioli M
PLoS Genet; 2019 Mar; 15(3):e1007765. PubMed ID: 30897080
[TBL] [Abstract][Full Text] [Related]
8. Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.
Duan W; Peng Q; Masuda N; Ford E; Tryggestad E; Ladenheim B; Zhao M; Cadet JL; Wong J; Ross CA
Neurobiol Dis; 2008 Jun; 30(3):312-322. PubMed ID: 18403212
[TBL] [Abstract][Full Text] [Related]
9. Selective neuronal requirement for huntingtin in the developing zebrafish.
Henshall TL; Tucker B; Lumsden AL; Nornes S; Lardelli MT; Richards RI
Hum Mol Genet; 2009 Dec; 18(24):4830-42. PubMed ID: 19797250
[TBL] [Abstract][Full Text] [Related]
10. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse.
Wheeler VC; Auerbach W; White JK; Srinidhi J; Auerbach A; Ryan A; Duyao MP; Vrbanac V; Weaver M; Gusella JF; Joyner AL; MacDonald ME
Hum Mol Genet; 1999 Jan; 8(1):115-22. PubMed ID: 9887339
[TBL] [Abstract][Full Text] [Related]
11. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.
Schilling G; Becher MW; Sharp AH; Jinnah HA; Duan K; Kotzuk JA; Slunt HH; Ratovitski T; Cooper JK; Jenkins NA; Copeland NG; Price DL; Ross CA; Borchelt DR
Hum Mol Genet; 1999 Mar; 8(3):397-407. PubMed ID: 9949199
[TBL] [Abstract][Full Text] [Related]
12. Huntington disease.
Vonsattel JP; DiFiglia M
J Neuropathol Exp Neurol; 1998 May; 57(5):369-84. PubMed ID: 9596408
[No Abstract] [Full Text] [Related]
13. HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington's disease mice.
Chen L; Qin Y; Guo T; Zhu W; Lin J; Xing T; Duan X; Zhang Y; Ruan E; Li X; Yin P; Li S; Li XJ; Yang S
Cell Death Dis; 2024 May; 15(5):337. PubMed ID: 38744826
[TBL] [Abstract][Full Text] [Related]
14. Pin1-Catalyzed Conformation Changes Regulate Protein Ubiquitination and Degradation.
Jeong J; Usman M; Li Y; Zhou XZ; Lu KP
Cells; 2024 Apr; 13(9):. PubMed ID: 38727267
[TBL] [Abstract][Full Text] [Related]
15. Mono- and Biallelic Inactivation of Huntingtin Gene in Patient-Specific Induced Pluripotent Stem Cells Reveal HTT Roles in Striatal Development and Neuronal Functions.
Louessard M; Cailleret M; Jarrige M; Bigarreau J; Lenoir S; Dufour N; Rey M; Saudou F; Deglon N; Perrier AL
J Huntingtons Dis; 2024; 13(1):41-53. PubMed ID: 38427495
[TBL] [Abstract][Full Text] [Related]
16. CAG repeat expansion in the Huntington's disease gene shapes linear and circular RNAs biogenesis.
Ayyildiz D; Bergonzoni G; Monziani A; Tripathi T; Döring J; Kerschbamer E; Di Leva F; Pennati E; Donini L; Kovalenko M; Zasso J; Conti L; Wheeler VC; Dieterich C; Piazza S; Dassi E; Biagioli M
PLoS Genet; 2023 Oct; 19(10):e1010988. PubMed ID: 37831730
[TBL] [Abstract][Full Text] [Related]
17.
Laundos TL; Li S; Cheang E; De Santis R; Piccolo FM; Brivanlou AH
Front Cell Dev Biol; 2023; 11():1252521. PubMed ID: 37727506
[No Abstract] [Full Text] [Related]
18. Toxic effects of mutant huntingtin in axons are mediated by its proline-rich domain.
Brady ST; Mesnard-Hoaglin NA; Mays S; Priego M; Dziechciowska J; Morris S; Kang M; Tsai MY; Purks JL; Klein A; Gaona A; Melloni A; Connors T; Hyman B; Song Y; Morfini GA
Brain; 2024 Jun; 147(6):2098-2113. PubMed ID: 37633260
[TBL] [Abstract][Full Text] [Related]
19. From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research.
Jiang A; Handley RR; Lehnert K; Snell RG
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629202
[TBL] [Abstract][Full Text] [Related]
20. Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome.
Capuz A; Osien S; Cardon T; Karnoub MA; Aboulouard S; Raffo-Romero A; Duhamel M; Cizkova D; Trerotola M; Devos D; Kobeissy F; Vanden Abeele F; Bonnefond A; Fournier I; Rodet F; Salzet M
Cell Death Dis; 2023 Aug; 14(8):526. PubMed ID: 37587118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
